Businesses Solutions • FinTech (& Financials services) • Retail (& E-Commerce) • A.I. (& Big Data) • HealthTech (& Fitness) • Future Of Work • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Mobility
Description
Partner at Index Ventures
Martin Mignot serves as a Partner at Index Ventures. He also serves as Advisory Board Member at TheFamily. He specialises in SaaS, marketplaces, bitcoin and mobile. He worked on 50+ transactions to date, including Assistly, Auxmoney, BaseCRM, Cloud.com, Codecademy, DimDim, Factual, Farfetch, Flipboard, Funding Circle, Gluster, HouseTrip, Just Eat, Lookout, Nasty Gal, Notonthehighstreet, onefinestay, PeoplePerHour, TrustPilot, Soluto and SoundCloud. He is actively looking after Index's investments in Algolia, Capitaine Train, Drivy, Rad and Swiftkey. Prior to joining Index, Martin was in the TMT team at UBS Investment Bank and cofounded the beauty subscription business Boudoir Prive (acquired by Joliebox/Birchbox) and a student web radio service.
Petteri Koponen
Investing in IoT (& Wearables) • HealthTech ...
Helsinki, Finland
Previous Investments
• Iceye:
$13000000 (Later stage VC)
• Enevo:
$12000000 (Later stage VC)
• BetterDoctor:
$11000000 (Later stage VC)
• Synoste:
$5940000 (Early stage VC)
• Minima Processor:
$5500000 (Seed Round)
• The Curious AI Company:
$3670000 (Later stage VC)
Mr. Aaron Perman serves as Principal at S3 Ventures. He also served as Chief Executive Officer at Qualia. He is also an Angel Investor. Prior to joining S3, he invested in small-cap publicly traded companies at Western Standard, a long/short equity hedge fund. Earlier in his career, he spent time in the corporate strategy group at Southern California Edison and started a successful small business liquidating computer hardware. He serves as a mentor for the DivInc Accelerator and leads the Emerging Venture Capitalist Association's Austin chapter. He received his BS in International Business from the University of Southern California.
Demi Obayomi
Investing in Software (Web Marketplace Saas..) &b...
San Francisco Bay Are..., U.S.A.
Previous Investments
• Zuora:
$115000000 (Later stage VC)
• Gong.io:
$65000000 (Later stage VC)
• Datameer:
$40000000 (Later stage VC)
• Airware:
$30000000 (Later stage VC)
• Aircall:
$29000000 (Later stage VC)
• Origami Logic:
$25000000 (Later stage VC)
• ProsperWorks:
$24000000 (Later stage VC)
• FirstFuel Software:
$23000000 (Later stage VC)
• Gong.io:
$20000000 (Early stage VC)
• Aviso, Inc.:
$15000000 (Later stage VC)
• Routefusion:
$3800000 (Early stage VC)
• NextWorld Capital:
• FirstMark Capital:
(late stage)
• 500 Startups:
(mid stage)
• A-Level Capital, LLC:
(early stage)
• Goldman Sachs:
• Jama Cocoa:
(early stage)
• Maryland Venture Fund:
(mid stage)
• VERALOX Therapeutics:
(early stage)
• Maryland Momentum Fund:
(early stage)
• The Abell Foundation:
• McGuireWoods Capital Group:
Demi Obayomi
San Francisco Bay Area - New York - California, U.S.A.
Venrock invests in technology and healthcare. Individual focus areas: Biotechnology, Diagnostics, Genomics, Healthcare IT, Medical Devices. Prefers: category kings + big risk element
Eduardo Saverin
Investing in BioTech • Businesses Solutions ...
San Francisco Bay Are..., U.S.A. - Singapore - Brazil
Previous Investments
• iVideoSmart:
$3500000 (Series A)
• Sugar.fit:
$5000000 (Series A)
• Mswipe Technologies:
$20000000 (Series Unknown)
• Mswipe Technologies:
$31000000 (Series E)
• Mswipe Technologies:
$10000000 (Series D)
• Inspace XR:
$4000000 (Seed)
• Hopscotch:
$20000000 (Series E)
• Hopscotch:
$13000000 (Series C)
• Hopscotch:
$11000000 (Series B)
• CoinDCX:
$140000000 (Series D)
• CoinDCX:
$90000000 (Series C)
• Kopi Kenangan:
$96000000 (Series C)
• Kopi Kenangan:
$210000000 (Series B)
• Yalo:
$50000000 (Series C)
• Yalo:
$15000000 (Series B)
• Antler:
$50000000 (Series Unknown)
• Perx Technologies:
$5000000 (Series B)
• Perx Technologies:
$1000000 (Series A)
• Carro:
$30000000 (Series B)
• Carro:
$60000000 (Series B)
• CXA Group:
$25000000 (Series C)
• Tech in Asia:
$7000000 (Series Unknown)
• Tech in Asia:
$4000000 (Series C)
• INTURN:
$23000000 (Series B)
• 99.co:
$8000000 (Series A)
• 99.co:
$2000000 (Seed)
• Intelligent Video Solutions:
$4000000 (Series A)
• Jumio:
$4000000 (Debt Financing)
• Jumio:
$7000000 (Series A)
• Xfers:
$3000000 (Seed)
• Silvercar:
$28000000 (Series C)
• Silvercar:
$14000000 (Series B)
• RedMart:
$27000000 (Series C)
• RedMart:
$23000000 (Series B)
• RedMart:
$5000000 (Series Unknown)
• RedMart:
(Seed)
• Eat Just:
$90000000 (Series C)
• FlightCar:
$14000000 (Series A)
• Tag (Acquired):
$1000000 (Seed)
• Nitrous:
$7000000 (Series A)
• Nitrous:
$1000000 (Seed)
• ShopSavvy:
$7000000 (Series A)
• Qwiki:
$8000000 (Series A)
• Aporta, Inc.:
(Undisclosed)
• CrowdMob:
(Seed)
Eduardo Saverin
San Francisco Bay Area - Los Angeles, U.S.A. - Singapore - Brazil
Eduardo Saverin is a Co-Founder and serves as Partner at B Capital Group. He is a Co-Founder of Facebook. He also co-founded Velos Partners, a private equity firm based in Los Angeles and serves as its Chairman. He serves on the board of Carro, Connexions Asia and Ninja Van. He also serves as Advisor at Golden Gate Ventures.
Paul Silber
Investing in Software (Web Marketplace Saas..) &b...
Paul Silber serves as Co-Founding Principal at Blu Venture Investors. Silber also serves as Advisor at Evergreen Advisors and Insightin Health. Silber serves as Advisor at Evergreen Advisors and also serves as Board Member at Encore Path. He a native of Baltimore was the founder and President/CEO of In Vitro Technologies, (IVT), a bioscience company that provides products and services to pharmaceutical and biotechnology companies. After relocating to Baltimore in 1991, In Vitro grew from two employees to a staff of 70, including several employees in Europe. The company also expanded its international business to Japan, the U.K., and Germany, while bringing the products of international companies to their North American customers through strategic alliances and distribution relationships.
Liam Casey
Investing in Software (Web Marketplace Saas..) &b...
San Francisco Bay Are..., U.S.A. - Ireland
Previous Investments
• Plotlogic:
$28000000 (Series B)
• Greenwork:
$2000000 (Pre Seed)
• Coco:
$36000000 (Series A)
• Boomitra:
$4000000 (Seed)
• Station A:
$1000000 (Pre Seed)
• Oportun:
$1000000 (Seed)
• Tracworx:
$2000000 (Pre Seed)
• Pandas:
$6000000 (Pre Seed)
• &Open:
$7000000 (Seed)
• Nothing:
$7000000 (Seed)
• SISU Aesthetic Clinic:
$6000000 (Series A)
• SISU Aesthetic Clinic:
$1000000 (Seed)
• Trustap:
$800000 (Pre Seed)
• SODA SAYS:
$3000000 (Seed)
• Talivest:
$500000 (Angel)
• Stripe:
$2000000 (Seed)
Liam Casey
San Francisco Bay Area - California, U.S.A. - Ireland
Liam Casey is the Founder and serves as Chief Executive Officer of PCH. He also serves as a Board Member at Sisu Aesthetic Clinic. Prior to that, he served as the Marketing Director for Meadows & Byrne. He holds a Degree from Cork College Of Commerce.
How to connect with Angel Investors in the Medical Devices industry?
In the Medical Devices & Hospital Services industry, angel investors such as Esther Dyson, Vinod Khosla, and Steve Jurvetson are highly active. These investors focus on startups offering innovative solutions in medical technology, healthcare devices, and hospital services. Esther Dyson, an entrepreneur and investor, looks for companies that leverage technology to improve healthcare delivery and patient outcomes. Vinod Khosla, founder of Khosla Ventures, invests in medical device startups that have the potential to revolutionize patient care. Steve Jurvetson, a co-founder of Future Ventures, seeks out startups with scalable and impactful medical technology solutions. To connect with these investors, attend medical device conferences, healthcare expos, and networking events such as MedTech Conference, Health 2.0, and HIMSS. Utilize platforms like AngelList and LinkedIn to identify and reach out to potential investors. When pitching, emphasize how your medical device or hospital service solution addresses key challenges, such as improving patient care, enhancing operational efficiency, or reducing costs. Highlight any traction you’ve gained, such as partnerships with healthcare providers, successful clinical trials, or regulatory approvals. Building relationships through initial informal meetings or discussions at industry panels can help establish trust with these investors. Demonstrating the impact of your technology through case studies or clinical results can also add credibility. Personalize your outreach by referencing the investor’s previous investments and explaining how your venture aligns with their interests. Demonstrating a sustainable business model with clear revenue streams, such as product sales, licensing, or service contracts, will further strengthen your pitch. Leveraging endorsements or case studies from healthcare experts can also enhance your credibility.
Case Studies: Successful Funding Rounds with Angel Investors on Angels Partners
Exotic Orange & Angels Partners: Turning Financial Simplicity Into Investment Success
